Pathogenesis and treatment of refractory gastroesophageal reflux disease in Japanese patients
Fujiwara, Y.; Higuchi, K.; Yamamori, K.; Watanabe, Y.; Shiba, M.; Watanabe, T.; Tominaga, K.; Oshitani, N.; Matsumoto, T.; Arakawa, T.
Nihon Rinsho. Japanese Journal of Clinical Medicine 62(8): 1510-1515
2004
ISSN/ISBN: 0047-1852 PMID: 15344542 Document Number: 578791
Prevalence of refractory gastroesophageal reflux disease (GERD) defined as a patient who have persistent GERD symptoms during treatment with proton pump inhibitor (PPI) is rare in Japanese patinets. Pathogenesis of refractory GERD is associated with several factors including dysfunction of esophageal motility, presence of severe hiatal hernia, complication such as stricture and short esophagus, extensive metabolizer of CYP2C19 genotype, nocturnal gastric acid breakthrough, absence of H. pylori infection, or bile reflux. Examination by 24 hr pH monitoring is necessary to assess refractory GERD and if acid suppression is insufficient, treatment with double doses of PPIs or combination of PPI and H2 blocker is effective. However, most cases of refractory GERD are required surgical treatment. Endoscopic therapy might be useful for refractory GERD in future.